Phytochemical Profile and Apoptotic Activity of Onopordum cynarocephalum

Abstract

A phytochemical investigation of acetone and chloroform extracts of the aerial parts of Onopordum cynarocephalum Boiss. et Blanche was carried out. It led to the isolation of two new sesquiterpenes, the elemane aldehyde (2) and the eudesmane (11), together with 15 known compounds: two lignans (1 and 15) and 13 sesquiterpenes (3–10, 12–14, 16, 17). The structures were elucidated by spectroscopic analyses, especially 1D and 2D NMR spectra. The anti-growth effect against three human melanoma cell lines, M14, A375, and A2058, of the different extracts and compounds of O. cynarocephalum was also investigated. Among them, the chloroform extract exhibited the strongest biological activity, while the most active compounds were the lignan arctigenin (1), and the sesquiterpenes, compounds 3, 5, and 6 belonging to the elemane type, and 7 belonging to the eudesmane type. Our data also demonstrate that acetone and chloroform extracts induce, in the A375 cell line, apoptotic cell death that could be related to an overall action of the compounds present, but in particular to the lignans arctigenin (1) and the sesquiterpenes compounds 3–8 and 16. In fact, these molecules were able to induce a high DNA fragmentation, correlated to a significant increase of the caspase-3 enzyme activity. Furthermore, apoptosis appears to be mediated, at least in part, via PTEN activity and the inhibition of Hsp70 expression.

Key words

Onopordum cynarocephalum - Asteraceae - sesquiterpenes - melanoma - apoptosis - heat shock protein 70

• References

• 1 Ruwaiha A. Medical Treatment with herbs, 6th edition. Beirut: Dar-el-Qalam; 1981: 42-43
• 2 El-Najjar N, Saliba N, Talhouk S, Gali-Muhtasib H. Onopordum cynarocephalum induces apoptosis and protects against 1, 2 dimethylhydrazine-induced colon cancer. Oncol Rep 2007; 17: 1517-1523
• 3 Talhouk RS, Esseili MA, Kogan J, Atallah MR, Talhouk SN, Homaidan FR. Inhibition of endotoxin-induced pro-inflammatory markers by water extracts of Onopordum cynarocephalum and Achillea damascena . J Med Plants Res 2009; 3: 686-698
• 4 Bruno M, Maggio A, Rosselli S, Safder M, Bancheva S. The metabolites of the genus Onopordum (Asteraceae): chemistry and biological properties. Curr Org Chem 2011; 15: 888-927
• 5 Hartwell JL. Plants used against cancer. Lloydia 1968; 31: 71-170
• 6 Russo A, Piovano M, Lombardo L, Garbarino J, Cardile V. Lichen metabolites prevent UV light and nitric oxide-mediated plasmid DNA damage and induce apoptosis in human melanoma cells. Life Sci 2008; 83: 468-474
• 7 Rahman MMA, Dewick PM, Jackson DE, Lucas JA. Lignans of Forsythia intermedia . Phytochemistry 1990; 29: 1971-1980
• 8 Rustaiyan A, Nazarians L, Bohlmann F. Two new elemanolides from Onopordum leptolepis . Phytochemistry 1979; 18: 879-880
• 9 Garcia B, Skaltsa H, Navarro FI, Pedro JR, Lazari D. Sesquiterpene lactones and elemane derivatives from Onopordum myriacanthum . Phytochemistry 1996; 41: 1113-1117
• 10 Cardona ML, Garcia B, Pedro JR, Sinisterra JF. Sesquiterpene lactones and an elemane derivative from Onopordum corymbosum . Phytochemistry 1989; 28: 1264-1267
• 11 Cardona L, Bardon A, Garcia B, Pedro JR. Eudesmane and elemane derivatives from Onopordum acaulon . Phytochemistry 1993; 33: 1457-1460
• 12 Rustaiyan A, Ahamadi B, Jakupovic J, Bohlmann F. Sesquiterpene lactones and eudesmane derivatives from Onopordum carmanicum . Phytochemistry 1986; 25: 1659-1662
• 13 Braca A, De Tommasi N, Morelli I, Pizza C. New metabolites from Onopordum illyricum . J Nat Prod 1999; 62: 1371-1375
• 14 Mericli AH, Tuzlaci E. Constituents of Turkish Onopordum species. A new eudesmane from O. anatolicum . Pharmazie 1989; 44: 303
• 15 Koukoulitsa E, Skaltsa H, Karioti A, Demetzos C, Dimas K. Bioactive sesquiterpene lactones from Centaurea species and their cytotoxic/cytostatic activity against human cell lines in vivo . Planta Med 2002; 68: 649-652
• 16 Abuharfeil NM, Maraqa A, Von Kliest S. Augmentation of natural killer cell activity in vitro against cells by wild plants from Jordan. J Etnopharmacol 2000; 71: 55-63
• 17 Abuharfeil NM, Salim M, Von Kliest S. Augmentation of natural killer cell activity in vitro against tumour cells by some wild plants from Jordan. Phytother Res 2001; 15: 109-113
• 18 Csupor-Loffler B, Hajdu Z, Rethy B, Zupko I, Mathe I, Redei T, Falkay G, Hohmann J. Antiproliferative activity of Hungarian Asteraceae species against human cancer cell lines. Part II. Phytother Res 2009; 23: 1109-1115
• 19 Kim JY, Hwang JH, Cha MR, Yoon MY, Son ES, Tomida A, Ko B, Song SW, Shin-ya K, Hwang YI, Park HR. Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity. J Cell Physiol 2010; 224: 33-40
• 20 Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70
• 21 Negrín G, Eiroa JL, Morales M, Triana J, Quintana J, Estévez F. Naturally occurring asteriscunolide a induces apoptosis and activation of mitogen-activated protein kinase pathway in human tumor cell lines. Mol Carcinogen 2010; 49: 488-499
• 22 Bednarek I, Sypniewski D, Klama-Baryla A, Galka S, Machnik G. Single-cell gel electrophoresis (comet assay) as a tool for apoptosis determination in tumor cell lines HL-60 and Jurkat cultures treated with anisomycin. Ann Acad Med 2006; 60: 278-284
• 23 Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992; 267: 5317-5323
• 24 Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470
• 25 Callagy GM, Webber MJ, Pharoah PD, Caldas C. Meta-analysis confirms Bcl2 is an independent prognostic marker in breast cancer. BMC Cancer 2008; 8: 153
• 26 Krajewski S, Krajewska M, Turner BC, Pratt C, Howard B, Zapata JM, Frenkel V, Robertson S, Ionov Y, Yamamoto H, Perucho M, Takayama S, Reed JC. Prognostic significance of apoptosis regulators in breast cancer. Endocr Relat Cancer 1999; 6: 29-40
• 27 Zamzami N, Kroemer G. p 53 in apoptosis control: an introduction. Biochem Biophys Res Commun 2005; 331: 685-687
• 28 Russo AE, Torrisi E, Bevelacqua Y, Perrotta R, Libra M, McCubrey JA, Spandidos DA, Stivala F, Malaponte G. Melanoma: molecular pathogenesis and emerging target therapies (Review). Int J Oncol 2009; 34: 1481-1489
• 29 Wu H, Goel V, Haluska FG. PTEN signaling pathways in melanoma. Oncogene 2003; 22: 3113-3122
• 30 Ming M, He YY. PTEN: new insights into its regulation and function in skin cancer. J Invest Dermatol 2009; 129: 2109-2112
• 31 Patury S, Miyata Y, Gestwicki JE. Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem 2009; 9: 1337-1351
• 32 Ishihara K, Yamagishi N, Saito Y, Takasaki M, Konoshima T, Hatayama T. Arctigenin from Fructus Arctii is a novel suppressor of heat shock response in mammalian cells. Cell Stress Chaperones 2006; 11: 154-161
• 33 Bruno M, Rosselli S, Maggio A, Raccuglia RA, Bastow KF, Lee KH. Cytotoxic activity of some natural and synthetic guaianolides. J Nat Prod 2005; 68: 1042-1046
• 34 Bruno M, Rosselli S, Maggio A, Raccuglia RA, Bastow KF, Wu CC, Lee KH. Cytotoxic activity of some natural and synthetic sesquiterpene lactones. Planta Med 2005; 71: 1176-1178
• 35 Graham JG, Quinn ML, Fabricant DS, Farnsworth NR. Plants used against cancer – an extension of the work of Jonathan Hartwell. J Ethnopharmacol 2000; 73: 347-377